NS-863

· NS Pharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NS-863, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH) [Phase 2]